NEW ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION
$300,000N43FY2020AINIH
Regulus Therapeutics, Llc, San Diego CA
Investigators
Abstract
To support novel therapeutics for hepatitis B virus infection.
View original record on NIH RePORTER →